Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...

The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped ...

Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...

Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...